T helper (Th)17 cells constitute a distinct subset of CD4 þ helper T cells that is mainly characterized by abundant interleukin (IL)-17 production and is involved in the host defence against bacteria and fungi as well as in the pathogenesis of autoimmune diseases. The retinoic orphan receptor (ROR)gt directs the transcriptional activation of the IL17 gene. Here, we report the presence of a novel RORgt isoform, RORgt-D(5 --8), which lacks the hinge-encoding exons 5 --8 and represses potently IL17 and IL21 gene transcription. It thereby reduces the expression of multiple Th17-assigned cytokines. We propose that RORgt-D(5 --8) acts as a dominant-negative regulator of RORgt-mediated gene regulation and the balance between the full-length RORgt and the novel repressor isoform may arbitrate IL-17 production in human T cells.
INTRODUCTION

Interleukin (IL)-17A was identified a decade ago as a product of CD4
þ T helper (Th) cells and has been declared to be the lineagespecific cytokine of a distinct Th subset denoted as Th17 cells. 1, 2 In addition to IL-17A, Th17 cells produce other cytokines including IL-21, IL-22 and TNF-a. Excessive IL-17A production is prominent in several autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and systemic lupus erythematosus. 3 --5 Previous studies in animal models have demonstrated that IL-17A expression is mainly controlled by the ubiquitously expressed transcription factor retinoic acid-related orphan receptor (ROR)g and its immune cell-specific isoform RORgt. 6 Both proteins are encoded by the same genetic locus (Rorc) and belong to a large family of hormone nuclear receptors. 7, 8 Although they display high structural similarities, they differ in the amino-terminal sequence due to the use of two different promoters. 9 RORg À/À mice have been shown to exhibit reduced Th17 differentiation capacities and are less prone to develop IL-17A-triggered experimental autoimmune encephalomyelitis. 10 Of note, maximum RORgt-dependent IL-17A expression is orchestrated and maintained by additional cytokines (for example, IL-6, IL-21, IL-23 and transforming growth factor-b) and transcription factors such as STAT3, interferon (IFN)-regulatory factor-4, Runx transcription factor 1 and basic leucine zipper transcription factor ATF-like. 11 --14 It has been shown that forced expression of RORgt is sufficient to drive IL-17A production both in vitro and in vivo; 10 however, it remains elusive how RORgt expression itself is regulated and whether RORgt accounts for the increased expression of IL-17A in human T cells and especially in patients with autoimmune diseases.
In this communication, we report the presence and functional capacities of a novel shorter RORgt isoform, which suppresses the expression of IL-17A and related cytokines. We propose that the ratio between the full-length (fl) and the short isoform may determine the ultimate IL-17A production in humans T cells.
RESULTS AND DISCUSSION
Identification of novel RORct isoforms in primary human T cells Conventional RORgt-specific PCR using cDNA from primary human T cells did not only amplify the fl-RORgt sequence, but to our surprise, also two smaller RORgt fragments. Sequence analysis verified that these fragments indeed derived from RORgt. One of them lacked exons 6 --8, whereas a second one lacked exons 5 --8 of the fl-RORgt (Figure 1a) . The variant missing exons 5 --8, denoted as RORgt-D(5 --8), is of particular interest because the missing region exactly encodes for the hinge region of RORgt (Figure 1b ). This region bridges the highly conserved DBD (DNAbinding domain, within exons 2 and 3) and the moderately conserved ligand-binding domain of the retinoic orphan receptors. It has been shown to be required for proper protein:DNA interaction and to contribute to receptor interaction with additional transcriptional regulators in other isoforms of the ROR family. 15, 16 Intriguingly, activation of normal T cells with anti-CD3 and anti-CD28 antibodies for 5 h resulted in an increase of fl-RORgt mRNA expression, whereas it completely abrogated RORgt-D(5 --8) mRNA expression indicating a very rapid downregulation/degradation of RORgt-D(5 --8) after T-cell activation ( Figure 1c) . Next, we performed real-time qRT-PCR in unstimulated T cells obtained from a cohort of 11 healthy blood donor using two different primer sets, the first of which detecting an amplicon located at the N-terminus of RORgt (and thus detecting all RORgt isoforms) and a second one specifically detecting the newly identified RORgt-D(5 --8) variant since the reverse PCR primer was designed to cover the junction between exons 4 and 9 (as indicated underneath the schematic in Figure 1b We generated an expression plasmid encoding for RORgt-D (5 --8), transfected it into primary human T cells and validated its expression in nucleoprotein lysates by immunoblotting, which detected a protein of B45 kDa, hence 13 kDa smaller than the 58-kDa fl-RORgt ( Figure 1e As far as the relative mRNA and protein expression levels of the novel splice form are compared (Figures 1d and e) , it appears that expression of the shorter form is rather low as compared with the fl-RORgt; however, this comparison is certainly limited since protein stability and post-translational modifications may also affect the detection of the RORgt isoforms, and therefore complicate interpretations between mRNA and protein levels.
RORct-D(5 --8) effects on gene transcription of IL-17A and related cytokines
To analyze functional features of RORgt-D(5 --8), we transiently overexpressed it in primary human T cells and observed a significant reduction of IL-17A mRNA levels and also that of other cytokines of the Th17 family including IL-17F, IL-21 and IL-22, whereas transforming growth factor-b expression, not known to be regulated through RORgt, remained unaffected. However, forced expression of fl-RORgt either increased (IL-17F) or maintained expression levels of Th17 cytokines ( Figure 2a) . Next, we set out to further characterize the mechanism by which RORgt-D(5 --8) affects Th17 cytokine expression. Since the novel variant shares the same DBD as the wild-type isoform we hypothesized direct transcriptional effects. Reporter studies in primary human T cells revealed that RORgt-D(5 --8) acts as a strong repressor at both IL17A and IL21 promoters (Figure 2b ). The observed RORgt-D(5 --8) effects on IL17A gene transcription were also reflected in decreased IL-17A protein levels since its overexpression abrogated IL-17A production in effector T cells (CD45RA þ ) that are negative for both CD4 and CD8 expression (Figure 2c) . Similar experiments were performed in CD4 þ T cells; however, these cells did not produce any measurable levels of IL-17A (data not shown). Our data are in line with previous findings that CD4/CD8 doublenegative T cells are the major IL-17A producing T cell subset in various autoimmune diseases including systemic lupus erythematosus. 17 Next, we analyzed IL-17A production by ELISA in the supernatants of human T cells that had been transfected with pcDNA3, RORgt-D(5 --8) or fl-RORgt expression vectors. Since these experiments were performed in unactivated T cells, IL-17A levels were rather low; however, they were significantly decreased in cells overexpressing the novel RORgt isoform, whereas IFNg levels were not altered (Figure 2d) .
To further dissect the differential transcriptional activities mediated through the RORgt isoforms, we performed IL17A reporter studies in RORgt-deficient HEK293 HEK293T cells (Figure 3a Previous reports had also used HEK293T cells to analyze RORgtmediated IL17A gene transcription. 18 As shown in Figure 3b , RORgt-D(5 --8) significantly suppressed IL17A promoter-reporter activities (by 59 and 33%, respectively), whereas fl-RORgt activated it. Next, we performed IL17A reporter studies with increasing amounts of overexpressed RORgt-D(5 --8). Since primary human T cells display endogenous fl-RORgt levels, we used these cells to determine the competing behavior of the two RORgt isoforms (Figures 3c and d) . Our data offer proof of a dose-dependent, dominant-negative transcriptional effect of RORgt-D(5 --8) and showed that the already low RORgt-D(5 --8) protein amounts are able to downregulate IL17A promoter-reporter activity. We suspect a competition between the various RORgt isoforms at the IL17A promoter since both isoforms share the same DBD (located within exons 2 and 3 of the Rorc gene locus).
Taken together, this is the first report of an RORgt isoform, denoted as RORgt-D(5 --8), which rigorously suppresses IL-17A production in human T cells through direct transcriptional repression at both the IL17A and the IL21 promoter. RORgt-D(5 --8) counteracts the enhancing impact of fl-RORgt on IL17A gene transcription in a dose-dependent manner. Because both isoforms share the same DBD the presence or absence of the exon 5 --8-encoded region determines whether it will serve as a transactivator or trans-repressor. Our findings may be of importance in understanding the molecular origin of increased IL-17A production in patients with autoimmune diseases. Future studies will disclose in what proportion the different RORgt isoforms are expressed to each other in T cells obtained from these patients. It appears that the ratio of RORgt proteins that bind to the IL17A promoter determines the ultimate levels of IL-17 production and the subsequent inflammatory response.
MATERIALS AND METHODS
Study subjects and cell culture
Primary human T cells were obtained from healthy blood donors at the Kraft Family Blood Donor Center (Dana-Farber Cancer Institute, Boston, MA, USA). The study was approved by the Institutional Review Board of Beth Israel Deaconess Medical Center, Boston, MA, USA. Peripheral venous blood was collected and primary T cells were purified and cultured as described previously. 19 HEK293T cells were cultured in Dulbecco's modified Eagle medium with 10% fetal bovine serum and 1% penicillin/ streptomycin.
Plasmid generation, cells and transient transfections
The proximal 2200, 1125, 465 and 195 bp of the human IL17A promoter and the proximal 490 and 1066 bp of the human IL21 promoter were PCR amplified and cloned into pGL3-Basic vector (Promega, Madison, WI, USA) via MluI and BglII restriction sites. Site-directed mutagenesis at the RORg(t) site (À186) within the IL17A promoter constructs was performed using the PfuI DNA polymerase (Stratagene, Santa Clara, CA, USA) and a targeting primer with the following sequence: 5 0 -gagagattcttctatgcaatcattgggggcgg-3 0 . To clone the RORgt-D(5 --8) expression plasmid, we used the overlay PCR cloning method. Specifically, two independent PCRs were performed using cDNA from primary human T cells and the following primer pairs: first PCR with a 5 0 -primer encoding for the 5 0 -end of exon 1 and a 3 0 -primer encoding for the 3 0 -end of exon 4 plus the first 15 bases of exon 9; second PCR with a 5 0 -primer encoding for the last 15 bases of exon 4 plus the 5 0 -end of exon 5 and a 3 0 -primer encoding for the 3 0 -end of exon 10. Subsequently, the two PCR-amplified fragments were mixed and used as the template for another PCR using primers that anneal to the 5 0 -end of exon 1 and 3 0 -end of exon 10. The amplicon was gel purified and cloned into pcDNA3 vector (Invitrogen, Carlsbad, CA, USA). Human fl-RORgt (accession no. NM_001001523) was synthesized and cloned into pcDNA3 by Genewiz (Cambridge, MA, USA). Transient transfections of primary human T cells were conducted for 5 h using the Amaxa electroporation system (Lonza, Basel, Switzerland). 18 For titration studies, 3 million primary human T cells were transfected with 750 ng of the reporter plasmid, the indicated amounts of RORgt-D(5 --8). Equal amounts of total plasmid DNA (3 mg per transfection) were maintained by co-transfection with pcDNA3 EV. HEK293T cells were transfected by Lipofectamine (Invitrogen) using 200 000 cells and a total of 4 mg of plasmid DNA per transfection (1:3 reporter:effector ratio). Cells were collected 24 h after transfection, assayed for luciferase activity or subjected to nucleoprotein preparation and immunoblotting as described below.
Luciferase assays, mRNA extraction, RT-PCR and real-time qPCR
These techniques were performed as described before. 19 Sequences of primers used for conventional RT-PCR and qPCR are given in Supplementary Table 1 .
Western blotting and flow cytometry Cytoplasmic and nuclear proteins were extracted and analyzed by SDS-PAGE and subsequent immunoblotting as described previously. 19 Polyclonal anti-RORg(t) (Santa Cruz, Santa Cruz, CA, USA) and secondary HRPlinked anti-rabbit Ab (Santa Cruz) were used for protein detection. For 
